142 related articles for article (PubMed ID: 27524528)
41. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
42. Yield of unpredicted bone-marrow relapse diagnosed by routine marrow aspiration in children with acute lymphoblastic leukaemia. A report from the Children's Cancer Study Group.
Rogers PC; Bleyer WA; Coccia P; Lukens JN; Siegel S; Sather H; Hammond D
Lancet; 1984 Jun; 1(8390):1320-2. PubMed ID: 6145026
[TBL] [Abstract][Full Text] [Related]
43. Outcome of childhood acute lymphoblastic leukaemia after induction therapy--3 years experience at a single paediatric oncology centre.
Rana ZA; Rabbani MW; Sheikh MA; Khan AA
J Ayub Med Coll Abbottabad; 2009; 21(4):150-3. PubMed ID: 21067050
[TBL] [Abstract][Full Text] [Related]
44. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
[TBL] [Abstract][Full Text] [Related]
45. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse.
Martínez-Laperche C; Gómez-García AM; Lassaletta Á; Moscardó C; Vivanco JL; Molina J; Fuster JL; Couselo JM; de Toledo JS; Bureo E; Madero L; Ramírez M
Am J Hematol; 2013 May; 88(5):359-64. PubMed ID: 23468276
[TBL] [Abstract][Full Text] [Related]
46. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
47. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
Badowska W
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
[TBL] [Abstract][Full Text] [Related]
48. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
[TBL] [Abstract][Full Text] [Related]
49. Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse.
Hijiya N; Gajjar A; Zhang Z; Sandlund JT; Ribeiro RC; Rubnitz JE; Jeha S; Liu W; Cheng C; Raimondi SC; Behm FG; Rivera GK; Relling MV; Pui CH
Leukemia; 2004 Oct; 18(10):1581-6. PubMed ID: 15356657
[TBL] [Abstract][Full Text] [Related]
50. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
[TBL] [Abstract][Full Text] [Related]
51. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
Pui CH; Pei D; Coustan-Smith E; Jeha S; Cheng C; Bowman WP; Sandlund JT; Ribeiro RC; Rubnitz JE; Inaba H; Bhojwani D; Gruber TA; Leung WH; Downing JR; Evans WE; Relling MV; Campana D
Lancet Oncol; 2015 Apr; 16(4):465-74. PubMed ID: 25800893
[TBL] [Abstract][Full Text] [Related]
52. Correlation between cranial computed tomographic scans at diagnosis in children with acute lymphoblastic leukaemia and central nervous system relapse.
Jankovic M; Scotti G; De Grandi C; Zanetto F; Colella R; Di Tullio MT; Lippi A; Scattolin O; Vecchi V; Riccardi R
Lancet; 1988 Nov; 2(8622):1212-4. PubMed ID: 2903952
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia.
Morris EC; Harrison G; Bailey CC; Hann IM; Hill FG; Gibson BE; Richards S; Webb DK;
Br J Haematol; 2003 Mar; 120(5):787-9. PubMed ID: 12614210
[TBL] [Abstract][Full Text] [Related]
54. Orbital relapse in children treated for Pre-B ALL, a retrospective case series.
Seher K; Khan SJ
J Pak Med Assoc; 2021 Jan; 71(1(B)):360-362. PubMed ID: 35157681
[TBL] [Abstract][Full Text] [Related]
55. Isolated optic nerve involvement in acute lymphoblastic leukaemia: a red flag for early relapse.
Azad SV; Banerjee M; Parmanand K; Venkatesh P
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34183317
[TBL] [Abstract][Full Text] [Related]
56. Clinico-Haematologic Parameters And Assessment Of Post-Induction Status In Acute Lymphoblastic Leukaemia.
Niaz H; Malik HS; Mahmood R; Mehmood A; Zaidi SA; Nisar U
J Ayub Med Coll Abbottabad; 2022; 34(3):458-462. PubMed ID: 36377156
[TBL] [Abstract][Full Text] [Related]
57. High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia.
Ryalls MR; Pinkerton CR; Meller ST; Talbot D; McElwain TJ
Med Pediatr Oncol; 1992; 20(2):119-23. PubMed ID: 1734216
[TBL] [Abstract][Full Text] [Related]
58. The pretreatment DNA labelling index of the blast cells of patients with acute lymphoblastic leukaemia as a prognostic factor in the outcome of treatment: the concept of 'G-0 acute leukaemia'.
Béjar-Lozano C; Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Marín-López A
Clin Lab Haematol; 1989; 11(4):339-48. PubMed ID: 2605875
[TBL] [Abstract][Full Text] [Related]
59. New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia.
van der Velden VH; de Launaij D; de Vries JF; de Haas V; Sonneveld E; Voerman JS; de Bie M; Revesz T; Avigad S; Yeoh AE; Swagemakers SM; Eckert C; Pieters R; van Dongen JJ
Br J Haematol; 2016 Mar; 172(5):769-81. PubMed ID: 26898195
[TBL] [Abstract][Full Text] [Related]
60. Low spontaneous apoptosis index at diagnosis predicts a high-risk phenotype in paediatric acute lymphoblastic leukaemia.
Singh A; Bhatia P; Trehan A; Bansal D; Singh A; Bhatia A
Indian J Med Res; 2018 Mar; 147(3):248-255. PubMed ID: 29923513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
